Vertex Pharmaceuticals Director Files Intent to Sell $663K in Stock
Vertex Pharmaceuticals Incorporated
Subscribe to track VRTX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Vertex Pharmaceuticals ($VRTX) Director, Bruce I. Sachs, has filed a notice of proposed sale for 1,210 shares of common stock, valued at approximately $662,536. The sale is planned for around August 27, 2026. The shares are being sold through the Watercove Charitable Foundation, where Mr. Sachs serves as a trustee.
Comprehensive Analysis
Bruce I. Sachs, a Director at Vertex Pharmaceuticals (NASDAQ: VRTX), has filed a Form 144 indicating a proposed sale of 1,210 shares of common stock. The total value of the intended transaction is approximately $662,536, based on an aggregate market value of $662,535.50. The approximate date for the sale is August 27, 2026.
According to the filing's remarks, the shares are being sold through the Watercove Charitable Foundation, for which Mr. Sachs serves as a trustee. The shares were originally acquired as a gift. Sales conducted through charitable foundations are often related to philanthropic goals or portfolio management within the foundation and may not necessarily reflect a change in the insider's personal conviction in the company's future prospects. Given the context and moderate value, the significance of this transaction is considered low.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.